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Most human cytomegalovirus (HCMV) genes are
highly conserved in sequence among strains, but
some exhibit a substantial degree of variation.
Two of these genes are UL146, which encodes a
CXC chemokine, and UL139, which is predicted to
encode a membrane glycoprotein. The sequen-
ces of these genes were determined from a
collection of 184 HCMV samples obtained from
Africa, Australia, Asia, Europe, and North Amer-
ica. UL146 is hypervariable throughout, whereas
variation in UL139 is concentrated in a sequence
encoding a potentially highly glycosylated
region. The UL146 sequences fell into 14 geno-
types, as did all previously reported sequences.
The UL139 sequences grouped into 8 genotypes,
and all previously reported sequences fell into a
subset of these. There were minor differences
among continents in genotypic frequencies for
UL146 and UL139, but no clear geographical
separation, and identical nucleotide sequences
were represented among communities distant
from each other. The frequent detection of multi-
ple genotypes indicated that mixed infections are
common. For both genes, the degree of diver-
gence was sufficient to preclude reliable
sequence alignments between genotypes in the
most variable regions, and the mode of evolution
involved in generating the genotypes could not
be discerned. Within genotypes, constraint
appears to have been the predominant mode,
and positive selection was detected marginally at
best. No evidence was found for linkage disequi-
librium. The emerging scenario is that the HCMV
genotypes developed in early human popula-
tions (or even earlier), becoming established via
founder or bottleneck effects, and have spread,
recombined and mixed worldwide in more
recent times. J. Med. Virol. 80:1615–1623,
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INTRODUCTION
Human cytomegalovirus (HCMV; family Herpesvir-
idae, subfamily Betaherpesvirinae, genus Cytomegalo-
virus, species Human herpesvirus 5) is ubiquitous and
host-specific. Infection is asymptomatic for most people,
but can result in serious disease in immunocompro-
mised individuals and congenitally infected newborns.
The minimally passaged Merlin strain is considered best
to represent wild-type HCMV, and has a 236 kbp
genome that is predicted to contain approximately 165
protein-encoding genes [Dolan et al., 2004].
Most genes are highly conserved in sequence between
HCMV strains, but a number of genes predicted to
encode membrane-associated or secreted proteins are
characterized by a striking degree of variability, as
revealed by examination of individual genes [reviewed
in Pignatelli et al., 2004] and by whole genome
comparisons [Murphy et al., 2003; Dolan et al., 2004].
Various studies have attempted to make connections
between the genotypes of hypervariable genes and
disease outcome, and overall the conclusions reached
are unclear or contradictory [reviewed in Puchhammer-
Sto¨ckl and Go¨rzer, 2006]. The apparently random
association of genotypes at different loci (that is, the
absence of linkage disequilibrium), presumably as a
result of recombination during HCMV evolution, limits
any conclusions to the specific gene under study, except
in some cases where genes are very close to each other or
encode interacting hypervariable proteins [Rasmussen
et al., 2002, 2003]. A further complicating factor is the
occurrence of multiple HCMV genotypes in individuals,
including immunocompromised patients, pregnant
women and congenitally infected newborns [for recent
papers, see Rasmussen et al., 2003; Hassan-Walker
et al., 2004; Stanton et al., 2005; Puchhammer-Sto¨ckl
et al., 2006; Iwasenko et al., 2007].
One of the most variable HCMV genes is UL146,
which encodes a chemokine designated vCXC-1. This
gene is variable throughout its length [Penfold et al.,
1999; Prichard et al., 2001; Hassan-Walker et al., 2004;
Arav-Boger et al., 2005, 2006; Stanton et al., 2005; He
et al., 2006; Lurain et al., 2006], and 14 genotypes have
been catalogued [Dolan et al., 2004]. In strain Toledo,
UL146 encodes a functional chemokine that is capable of
neutrophil degranulation, chemotaxis and calcium
mobilization. This protein contains an ELRCXC motif,
which has been shown to be essential for receptor
binding and IL-8 activity [Clark-Lewis et al., 1991].
vCXC-1 binds to human CXCR2 and is comparable in its
activities to CXC chemokines IL-8 and gro-a [Penfold
et al., 1999]. The function of vCXC-1 may be to facilitate
dissemination of the virus through its ability to attract
monocytes to the initial site of infection. Thus, the virus
could undermine the effectiveness of antiviral immunity
by manipulating the host chemokine system and,
together with other virus-encoded molecular mimics,
suppressing the immune system.
The most variable gene in the vicinity of UL146 is
UL139, which is located 5.2 kbp distant and is predicted
to encode a type I membrane glycoprotein. Variability is
concentrated in a region of the ectodomain [Dolan et al.,
2004]. A recent study of 26 HCMV strains isolated in
China described three major genotypes, with two of
these divided into subtypes [Qi et al., 2006].
The aims of the present study were to investigate
whether additional UL146 genotypes exist in a large
number of clinical samples obtained from a wide range of
locations and clinical settings, and to define the range of
UL139 genotypes in these samples. Ancillary interests
were to examine the relative frequencies and geo-
graphical distribution of genotypes, to assess whether
infections with more than one HCMV strain are
common, and to investigate the evolution of UL146
and UL139.
MATERIALS AND METHODS
Virus DNA Collection
A collection of 184 DNA samples was derived from 179
anonymized clinical samples obtained in various geo-
graphical locations in accordance with local ethical
guidelines, plus 5 commonly used laboratory strains
(Davis, Merlin, TB40/E, Toledo and Towne). Details of
the 171 samples in the collection that yielded sequence
data are available on request, and include the age, sex,
and pathology of the patient, the clinical source of the
sample, and the UL146 and UL139 genotypes deter-
mined. The samples numbered 18 from Australia, 10
from Hong Kong, 6 from Germany, 13 from England, 18
from The Gambia, 24 from Hungary, 7 from Italy, 6 from
The Netherlands, 41 from Scotland, 5 from the USA, 8
from Wales, and 15 from South Africa. A minority of
strains (40) had been passaged in human fibroblast cell
culture, either as routine diagnostic specimens or as
laboratory strains. DNA was extracted by standard
methods from body tissues, urine, saliva or infected
cells. The South African samples were obtained from
the saliva of mothers (10 of whom tested HIV-negative)
attending rural clinics in KwaZulu/Natal [Dedicoat
et al., 2004]. Since these were available in very
limited amounts and contained low numbers of HCMV
genomes, whole genome amplification using a REPLI-
g kit (Qiagen, Crawley, UK) was carried out prior to PCR
amplification.
PCR Amplification
UL146 and UL139 were amplified separately by single
round or nested PCR, using primers in conserved
regions (Table I). Single (and first) round PCR of
UL146 using AB4 and A162 generated a product of
approximately 1 kbp, and second round PCR using
UL146-4A and UL146-3A yielded an 800 bp product.
Single (and first) round PCR of UL139 using AB1 and
AB2 generated an 800 bp product, and nested PCR using
UL140-3A and UL140-11A yielded a 500 bp product.
UL140-11A is located within the UL139 coding region,
and as a consequence the sequences obtained using
nested PCR (approximately 40% of the total) lacked 29
J. Med. Virol. DOI 10.1002/jmv
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amino acid-encoding codons from the highly conserved C
terminus.
For the single (and first) round, 1 ml of DNA was added
to the PCR reaction mixture, which consisted of 40 ml of
water, 5 ml of buffer, 1 ml of 10 mM dNTPs, 1 ml of each the
two primers (10 mM) and 1 ml (1 U) of DNA polymerase
(Advantage 2, BD Clontech, Basingstoke, UK). The
conditions for amplification were 958C for 2 min followed
by 35 cycles of 958C for 2 min, 608C for 30 sec and 688C for
1 min. Second round PCR utilized 1 ml of first round PCR
products as template amplified under the same con-
ditions. PCR reactions were set up in a dedicated, PCR
product-free room. Approximately one-third of the
samples were tested on three separate occasions to
assess reproducibility.
Purification, Cloning, and Sequencing
of PCR Products
PCR products were separated by agarose gel electro-
phoresis. Appropriate DNA fragments were excised,
purified using a Geneclean turbo kit (Q Biogene,
Cambridge, UK), and eluted using 100 ml of nuclease-
free water. The single round or second round primers
were used for direct sequencing.
In some cases, including those where direct sequenc-
ing indicated the presence of more than one genotype
of UL146 or UL139, fragments were cloned using a
pGEM-T kit (Promega, Southampton, UK). Following
ligation and transformation into chemically competent
E. coli TOP 10 cells, 5 recombinant colonies were picked
and grown overnight at 378C in 2YT-broth containing
100 mg/ml ampicillin. Plasmid DNA was purified using a
QIAprep Spin miniprep kit (Qiagen). Plasmid inserts
were sequenced using universal forward and reverse
primers. Sequencing was carried out on both DNA
strands using a BigDye terminator kit (Applied
Biosystems, Warrington, UK) in an ABI 3730 instru-
ment. Samples containing multiple strains were identi-
fied by the derivation of plasmids representing different
genotypes of UL146 or UL139.
Sequence Analysis
Sequence chromatograms were viewed using Edit-
view (Applied Biosystems) and analyzed using Pregap4
and Gap4 [Staden et al., 2000]. Nucleotide and imputed
amino acid sequences were aligned using CLUSTAL W
[Thompson et al., 1994] and MAFFT [Katoh et al., 2005].
Full-length sequences were used for the UL146 data and
a subset of the UL139 data, and another subset of the
UL139 data was analyzed using sequences lacking the
conserved C terminus. MEGA4.0 [Tamura et al., 2007]
was used for the generation of phylogenetic trees.
Frequencies of nonsynonymous and synonymous differ-
ences per site (dN and dS, respectively) and degree of
sequence variability (nucleotide and amino acid) were
investigated using Swaap 1.0.1 [Pride, 2004], DnaSP
4.10.9 [Rozas et al., 2003], and MEGA4.0. dN/dS ratios
and probabilities of positive selection were assessed
using PAML 3.15 [Yang, 1997]. Signal peptide and
transmembrane sequences were predicted using Pho-
bius [Kall et al., 2004].
Statistical Analysis
Sample origin was divided into four regions (Africa,
Asia, Europe, and Australia) for assessment of the
geographical distribution of genotypes. Chi-square tests
were used to assess the significance of variability of
genotype frequencies among regions. Yates’ correction
for continuity was applied to chi-square tests in cases
where the expected values fell below 5. Similarly, Chi-
square tests with Yates’ correction were applied to 60
samples where single genotypes were detected for both
UL146 and UL139, in order to test for linkage disequi-
librium. Samples containing mixed infections were
excluded from this analysis.
RESULTS
UL146 and UL139 Sequences
The UL146 and UL139 genotypes in 184 samples were
investigated by PCR and sequencing using primers in
conserved regions. UL146 was amplified from 159
samples and sequences were determined from 134, and
UL139 was amplified from 168 samples and sequences
determined from 131. A total of 13 samples failed to yield
products from either gene. Since some samples con-
tained more than one virus strain, totals of 182 UL146
sequences and 183 UL139 sequences were obtained.
Alignment and phylogenetic analyses involved the
350 UL146 sequences and 300 UL139 sequences derived
J. Med. Virol. DOI 10.1002/jmv
TABLE I. Primers Used for PCR and Sequencing
Gene Primer Sequence (50–30) Genome locationa
UL146 AB4 TAGACACTACGTCGTAAATG 180494–180513
UL146 A162 TGTAGAATTAGTCTAGATTCCTGA 181524–181501
UL146 UL146-4A GCTTGCGCGTTAGGATTGAGACAC 180571–180594
UL146 UL146-3A ATACCGGATATTACGAATT 181341–181323
UL139 AB1 GTCATTGTGAAAGTGACGTCTCAG 186389–186412
UL139 AB2 ATCTACTGTAAACCCTCTGCTCTG 187148–187125
UL139 UL140-11A GCGGCATTGGTGTACGCGTG 186553–186572
UL139 UL140-3A GTGGAAATTTTTACGTCATT 187077–187058
aWith reference to RefSeq accession NC_006273.2 (HCMV strain Merlin).
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from the present study or reported by others in the
literature [Cha et al., 1996; Davison et al., 2003; Dolan
et al., 2004; Arav-Boger et al., 2005, 2006; Stanton et al.,
2005; He et al., 2006; Lurain et al., 2006; Qi et al., 2006]
or public sequence databases [AY999242-AY999271,
AY805250-AY805303, AY818250-AY818255, Mao et
al.; DQ229942–DQ229948, Ruan et al.; DQ180366,
DQ180358, DQ180374, DQ180386, Zhou et al.].
UL146 Genotypes
The UL146 coding sequences range in length from 114
to 126 codons, and phylogenetic analyses indicated that
all fall into the 14 genotypes defined previously and
designated G1–G14 [Dolan et al., 2004]. Amino acid
sequence variation among genotypes is high (p¼ 0.521,
where p is protein diversity from MEGA4.0), whereas
within each genotype it is low (p¼ 0–0.051 with a mean
of 0.017) (Table II).
Differences in overall genotypic frequencies were
observed (Table II). For example, G7 was detected in
16% of samples and G6 in fewer than 1%.
UL139 Genotypes
The UL139 coding sequences range in length from 124
to 148 codons, and phylogenetic analyses indicated that
all fall into 8 genotypes designated G1–G8. Figure 1A
shows a predicted amino acid sequence alignment of the
primary translation products of one representative of
each genotype. Figure 1B shows a phylogenetic tree
constructed using these sequences.
The protein encoded by each HCMV UL139 genotype
contains a putative signal peptide sequence and a
transmembrane region. Variation is concentrated in
the N-terminal portion of the protein. Amino acid
sequence variation between genotypes is high
(p¼0.275), whereas within each genotype it is low
(p¼0.007–0.095 with a mean of 0.025) (Table III).
Variation within genotypes tends to be higher in UL139
than in UL146, but that among genotypes is lower.
Sequences in G1 exhibit a greater level of variation than
those in the other genotypes.
Differences in overall genotypic frequencies were
observed (Table III). For example, G2 was detected in
27% of samples and G8 in fewer than 3%.
Assessment of Positive Selection
In order to assess positive selection (i.e., for amino acid
sequence diversity), the dN/dS ratio was calculated for
each UL146 and UL139 genotype (Tables II and III).
Positive selection was detected at the 1% significance
level only in UL139 G1, and at the 5% level in UL146 G7
and G1. UL139 G6 and G7 and UL146 G2 and G13 also
had values of dN/dS>1, but these were not statistically
significant. Only in UL139 G1 was an amino acid residue
identified as under positive selection, although this was
at position 12 in the predicted signal peptide sequence.
Thus, evidence for positive selection is marginal, and it
seems unlikely that this mode of diversification has
featured in the evolution of UL139 and UL146 since the
genotypes arose. No strong evidence emerged for
positive selection in formal comparisons among geno-
types (i.e., as a factor in emergence of the genotypes), but
it must be registered that variation was so large as to
confound reliable sequence alignments.
Geographical Distribution of Genotypes
The sequence data derived in the present work were
divided into four groups representing strains obtained
from Africa, Asia, Australia, and Europe. Insufficient
sample numbers were obtained from America to war-
J. Med. Virol. DOI 10.1002/jmv
TABLE II. UL146 Diversity
Genotype Samples
Frequency
(%)
Alignment lengtha Diversity
dN/dSdDNA Protein DNAb Proteinc
G1 34 9.71 345 115 0.011 0.026 1.19e
G2 25 7.14 360 120 0.002 0.005 1.48
G3 10 2.86 375 125 0.010 0.016 0.50
G4 8 2.29 369 123 0.004 0.006 0.26
G5 16 4.57 348 116 0.007 0.012 0.71
G6 2 0.57 351 117 0.029 0.051 ND
G7 57 16.3 354 118 0.011 0.015 1.29e
G8 22 6.29 342 114 0.006 0.008 0.38
G9 49 14 351 117 0.017 0.032 0.94
G10 12 3.43 291 97 0.003 0.005 0.30
G11 19 5.43 339 113 0.007 0.015 0.50
G12 43 12.3 354 118 0.016 0.018 0.45
G13 47 13.4 357 119 0.007 0.015 1.58
G14 6 1.71 354 118 0 0 ND
All 350 100 225 75 0.642 0.521 0.27f
aGaps removed.
bJukes-Cantor Pi from DnaSP 4.10.9.
cProtein diversity p from MEGA4.0.
ddN/dS (omega) from PAML 3.15 under the single-rate model. ND, not determined.
eFive percent significance for positive selection.
fCalculated from a comparison of a single member of each genotype.
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rant inclusion. Observation of frequencies initially
suggested no significant differences in the distribution
of UL146 and UL139 genotypes among continents
(Tables IV and V). However, this conclusion may have
been compromised by insufficient sample numbers from
some areas (particularly Asia) and lack of information
on the ethnic origin of samples. This shortcoming is
highlighted by the observation that regions (specifically
J. Med. Virol. DOI 10.1002/jmv
Fig. 1. Phylogenetic analysis of UL139. A: Alignment (CLUSTAL W)
of amino acid sequences representing the eight genotypes. Predicted
signal peptide and transmembrane sequences are highlighted in gray.
Completely conserved residues are indicated in the consensus row
(con). Below this is the CCMV sequence, which is included to illustrate
conservation of the SETTTGTSSNSS motif (underlined). The CCMV
sequence [Davison et al., 2003] provided is the C-terminal portion (final
12 residues not shown) of a larger protein, the N-terminal portion of
which lacks a counterpart in HCMV but is related to a protein (encoded
by gene rh174) in rhesus cytomegalovirus. B: Unrooted neighbor-
joining tree for the HCMV amino acid sequences shown in (A),
computed using Mega4.0 (Poisson correction method with gaps
removed). Bootstrap values (out of 100) are shown, and values below
70 indicate regions of unresolved branching order. The scale bar
indicates the number of amino acid substitutions per site.
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Europe) for which a larger sample size was tested
displayed greater genotypic diversity. Nonetheless,
UL146 G13 appears somewhat more common in African
samples than in European samples (11 out of 45
sequences were detected in the former and 17 out of
104 in the latter), UL146 G10 and G11 appear to be
restricted to Europe (8 and 3 samples, respectively), and
the single sample of UL146 G6 originated from Asia.
Identical nucleotide sequences were frequently
obtained from geographically distant and presumably
epidemiologically unrelated patients. For example,
certain samples from The Gambia, Scotland, and
Hungary contained identical UL146 G12 sequences.
Also, UL139 G2, which was identified in 27% of samples,
was represented by identical sequences from Hungary,
The UK, and The Gambia.
Linkage Disequilibrium Between
UL146 and UL139
Potential linkage disequilibrium was investigated in
60 strains for which single genotypes of both UL146 and
UL139 were obtained. Of 112 possible genotype pairs, 41
were observed at least once (Table VI). No statistical
significance was obtained for the observed distribution
of genotype pairs versus a null hypothesis of independ-
ent assortment, indicating an absence of linkage
disequilibrium.
Infections With Multiple Strains
Multiple genotypes in one or both genes were detected
in at least 14% of samples upon first analysis (rising to
29% when repeat experiments were included), distrib-
uted among immunocompetent and immunocompro-
mised individuals. More than one genotype was detected
in 11% of European samples, 16% of Gambian samples,
47% of South African samples, and 10% of Hong Kong
samples (rising to 24%, 33%, 60%, and 60%, respectively,
when repeat experiments are included).
DISCUSSION
This study focused on the genotype definitions,
frequencies, occurrence in mixed infections, geograph-
ical distribution and evolution (in terms of linkage
disequilibrium and mode of selection) of two hyper-
variable HCMV genes, UL146 and UL139. Totals of 182
UL146 and 183 UL139 sequences were obtained from a
J. Med. Virol. DOI 10.1002/jmv
TABLE III. UL139 Diversity
Genotype Samples
Frequency
(%)
Alignment lengtha Diversity
dN/dSdDNA Protein DNAb Proteinc
G1 48 16 255 85 0.059 0.095 0.82e
G2 82 27.33 240 80 0.009 0.009 0.76
G3 29 9.66 339 113 0.014 0.013 0.34
G4 68 22.66 201 67 0.023 0.015 0.76
G5 28 9.33 255 124 0.018 0.024 0.65
G6 24 8 312 104 0.010 0.013 1.08
G7 14 4.66 237 79 0.006 0.015 2.38
G8 7 2.33 228 140 0.007 0.007 0.19
All 300 100 153 51 0.285 0.275 0.48f
aGaps removed.
bJukes-Cantor Pi from DnaSP 4.10.9.
cProtein diversity p from MEGA4.0.
ddN/dS (omega) from PAML 3.15 under the single-rate model.
eOne percent significance for positive selection.
fCalculated from a comparison of a single member of each genotype.
TABLE IV. Geographical Distribution of UL146 Genotypes
Genotype Africa Asia Europe Australia
G1 4 2 7 0
G2 2 1 7 2
G3 4 0 2 0
G4 1 0 4 2
G5 3 0 2 1
G6 0 1 0 0
G7 5 6 21 1
G8 2 0 5 0
G9 6 2 11 3
G10 0 0 8 0
G11 0 0 3 0
G12 5 1 16 0
G13 11 0 17 6
G14 2 0 1 0
Totals¼ 177 45 13 104 15
TABLE V. Geographical Distribution of UL139 Genotypes
Genotype Africa Asia Europe Australia
G1 8 2 16 2
G2 9 1 23 5
G3 1 4 7 0
G4 8 5 23 5
G5 10 3 14 0
G6 0 1 11 1
G7 3 0 5 5
G8 2 2 1 1
Totals¼ 178 41 18 100 19
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large panel of clinical isolates collected from Africa
(South Africa and The Gambia), Asia (Hong Kong),
Australia and Europe (various countries). These were
used in all analyses, and were supplemented by 168
previously published UL146 and 117 UL139 sequences
in analyses of genotype definitions, frequencies and
mode of selection.
The UL146 sequences fell into the 14 genotypes
described previously [Dolan et al., 2004], and no new
genotypes were discovered. Twelve genotypes contained
the ELRCXC motif, which has been shown to be
essential for receptor binding and IL-8 activity [Clark-
Lewis et al., 1991], and 2 contained the NGRCXC motif,
which has been shown to be important for interaction
with T and B cells [Baggiolini et al., 1997]. The latter
genotypes (G5 and G6) are relatively rare, being present
in approximately 5% of samples. It is not known whether
the UL146 genotypes possess different biological prop-
erties, and studies to investigate this question are
required.
The UL139 sequences grouped into eight genotypes. A
recent analysis of 26 clinical samples [Qi et al., 2006]
described three major groups (G1, G2, and G3), two of
which were divided into subgroups (G1 into G1a, G1b
and G1c and G2 into G2a and G2b). Subgroups G1b and
G1c in the previous study correspond to G1 in the
present study, subgroup G1a corresponds to G4,
subgroups G2a and G2b correspond to G6 and G2,
respectively, and G3 is named identically in both
studies. Thus, apart from the differences in nomencla-
ture, the subgroups [Qi et al., 2006] correlate with a
subset of the genotypes in the present study, except that
the closely related subgroups G1b and G1c in the former
are amalgamated as G1 in the latter. Most of the
variation in UL139 is due to substitutions or deletions of
variable size near the N terminus. This region is rich in S
and T residues that are potentially susceptible to O-
glycosylation, and also contains NXS or NXT motifs that
are potentially susceptible to N-glycosylation. This
suggests that selection may have focused primarily on
glycosyl side chains rather than the underlying amino
acid sequence. A similar feature characterizes other
variable glycoprotein genes, such as UL73 (encoding
glycoprotein N (gN)) and UL74 (encoding glycoprotein O
(gO)) [Pignatelli et al., 2001, 2003; Mattick et al., 2004].
A region of sequence identity (SETTTGTSSNSS in
Fig. 1A) has been noted between the HCMV UL139
protein and CD24, a cellular glycosyl phosphatidylino-
sitol-linked glycoprotein that is involved in B cell
activation [Qi et al., 2006]. It is difficult to assess the
significance of this observation, especially since 9 of the
12 residues are S or T and the region is not conserved in
CD24 orthologues from other mammals. However, the
sequence is present in all of the UL139 genotypes
identified in the present study, except for G5, and also in
the homologous protein from chimpanzee cytomegalo-
virus (CCMV) (Fig. 1A). Variation in glycosylation has
been observed in CD24 and has been linked to differ-
ences in cell and tissue specificity [Poncet et al., 1996].
Additional roles for CD24 in apoptosis and cell adhesion
have also been suggested, and more recently in regulat-
ing the responsiveness of a chemokine receptor, CXCR4
[Schabath et al., 2006; Smith et al., 2006]. The
possibility that UL139 may be a CD24 homologue
remains intriguing, but, in the absence of functional
data, unproven.
Studies of HCMV genotype frequency, including the
present one, are usually based on the use of conserved
PCR primers, and face limitations as a result. Firstly,
there is no guarantee that all genotypes will be detected,
since primers are chosen on the basis of alignments of
available sequences. Secondly, samples containing more
thanone strain yieldmixedsequences,whichwhen cloned
are recovered approximately in proportion to their
abundance (although stochastic processes may introduce
bias during PCR). Therefore, the absence of a genotype
from a particular sample cannot be assured. If any UL146
or UL139 genotypes have escaped recognition, they may
emerge from future studies involving different primers or
from whole genome sequencing exercises.
As found in previous studies [reviewed in Puch-
hammer-Sto¨ckl and Go¨rzer, 2006], mixed infections
with different HCMV strains were common. In some
samples, a single UL139 genotype and multiple UL146
genotypes, or vice versa, were detected. This could
be due to different strains happening to contain the
same genotype at one locus but not at the other, or to the
limitations of amplifying sequences present as mixtures
in unequal proportions. Some samples tested more than
once were found to contain additional genotypes not
detected in the first experiment, suggesting that the
number of mixed infections was underestimated by the
methodology used. Mixed infections were more fre-
quently detected from certain regions, namely Hong
Kong, South Africa and, to a lesser extent, The Gambia.
It is possible that this is a result of higher transmission
frequencies. In one study [Beyari et al., 2005], a higher
seroprevalence of HCMV in children in Malawi com-
pared to European countries and the USA was taken as
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TABLE VI. Analysis of Linkage Disequilibrium
UL146
genotype
UL139 genotype
G1 G2 G3 G4 G5 G6 G7 G8
G1 1 0 0 3 1 0 0 0
G2 1 1 0 0 0 0 0 0
G3 1 0 0 0 0 0 0 0
G4 0 0 1 1 0 0 0 1
G5 0 1 0 1 0 0 1 0
G6 0 0 0 0 0 0 0 0
G7 1 4 1 3 2 1 0 0
G8 0 1 0 1 1 0 1 0
G9 0 1 0 0 0 2 1 0
G10 0 3 0 1 0 0 0 0
G11 0 2 0 1 0 0 0 0
G12 1 1 1 1 2 1 0 0
G13 2 2 0 5 1 0 0 1
G14 1 0 0 0 0 0 0 0
Totals¼ 60 8 16 3 17 7 4 3 2
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possibly reflecting greater opportunities for transmis-
sion, although multiple genotypes were detected in only
a small number of samples.
The occurrence of mixed infections is being recognized
increasingly as potentially significant to the biology of
HCMV. This feature adds to the limitations inherent in
studies of whether particular genotypes are associated
with disease outcome; other features include the
number, origin and pathological categorization of
samples, the choice of gene, the absence of linkage
disequilibrium, and host factors. In light of these
limitations, our opinion is that robust evidence in favor
of any association between genotype and pathology has
proved elusive in the literature. Further work utilizing
genotype-specific approaches is required to explore the
true frequency of mixed infections, both to validate
studies of this type and to determine whether mixed
infections have geographical or biological correlates.
Similar to the conclusions drawn from a study on
UL73 (encoding gN) [Pignatelli et al., 2003], no statisti-
cally significant association of UL146 or UL139 geno-
types with geographical origin arose from the analysis.
However, this may reflect low sample numbers (albeit
much larger than those utilized in previous studies on
UL146 and UL139) and the lack of detailed information
on ethnic origin. Likewise, investigation of linkage
disequilibrium between UL146 and UL139 genotypes
was compromised by the small sample number (60)
relative to the large number of possible genotype
combinations (112). However, no evidence for linkage
disequilibrium was obtained, indicating the involve-
ment of recombination in HCMV evolution since the
genotypes arose. Taking into account the size of the
HCMV gene complement, we agree with the view that
very many strains are likely to be circulating in the
world [Rasmussen et al., 2003].
The extensive divergence between genotypes and the
consequent inability to produce reliable sequence align-
ments for both UL146 and UL139 in the hypervariable
regions compromised assessments of the role of positive
selection in generating the genotypes. In contrast,
variation within genotypes is low, and identical nucleo-
tide sequences were obtained from geographically
distant individuals. The analysis suggests that con-
straint has been the predominant factor in evolution
within genotypes, with positive selection detected only
marginally. A previous study [Arav-Boger et al., 2005]
involving 30 sequences also concluded that UL146 has
evolved under constraint. The sequences of hypervari-
able genes are stable on short timescales in patients
[Hassan-Walker et al., 2004; Stanton et al., 2005] and
cell culture [Lurain et al., 2006], consistent with the
perception of herpesvirus genomes as relatively slowly
evolving [McGeoch et al., 2006]. The most likely scenario
for the evolution of HCMV emerging from the literature
and from the present study is that the genotypes
developed in early human populations (or even earlier),
becoming established via founder or bottleneck effects,
and have spread, recombined and mixed worldwide in
more recent times, with mixed infections being common.
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